FDA Authorizes Two Siemens Covid-19 Serology Tests
By Malak Saleh
Aug. 1, 2020, 12:03 AM
The FDA authorized the first two Covid-19 serology tests produced by Siemens that display an estimated quantity of antibodies present in an individual’s blood.
The Adiva Centaur COV2G and Attelica COV2G tests estimate the quantity of a patient’s antibodies produced against infection with the virus that causes Covid-19
NOTE: July 29, FDA Authorizes New Quest Diagnostics Method for Covid-19 Tests
To contact the reporter on this story: Malak Saleh in New York at msaleh28@bloomberg.net
To contact the editor responsible for this story: Chakradhar Adusumilli at cadusumilli@bloomberg.net
